v3.26.1
Collaboration Agreements (Additional Information) (Details) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2026
May 31, 2024
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Research and development cost     $ 39,377 $ 30,126 $ 77,130 $ 64,031  
Accrued expenses and other current liabilities $ 4,226   4,226   4,226   $ 726
Commercial milestone payments         $ 1,150,000    
Proceeds From Issuance of Common Stock 712,900            
Share price percentage         90.00%    
Current liability $ 62,839   $ 62,839   $ 62,839   56,791
Private Placement [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Sale of stock price per share $ 18   $ 18   $ 18    
Proceeds From Issuance of Common Stock         $ 75,000    
Research Collaboration Agreement with ARTBIO, Inc.              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Research and development cost   $ 10,000 $ 0 800 0 2,400  
Increase (Decrease) in Operating Liabilities     0 500 0 1,400  
Reduction of research and development expenses       $ 300   $ 1,000  
Accrued expenses and other current liabilities $ 2,700   $ 2,700   2,700   $ 2,700
Research Collaboration Agreement with ARTBIO, Inc. | ARTBIO, Inc.              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Research and development cost   $ 10,000          
License and Collaboration Agreement with Regeneron              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Upfront payment $ 50,000       50,000    
Development milestone payments         $ 470,000    
Stock Issued During Period, Shares, New Issues         4,166,666    
Sale of stock price per share $ 18   $ 18   $ 18    
Proceeds From Issuance of Common Stock $ 75,000       $ 75,000    
Share price percentage         90.00%    
Transaction price of performance obligations 41,700   $ 41,700   $ 41,700    
Reduction Of The Transaction Price 8,300   8,300   8,300    
Commitment at fair value 83,300   83,300   83,300    
Contract With Customer Performance Obligation Unsatisfied Or Partially Unsatisfied 41,500   41,500   41,500    
Company recognized revenue     100   100    
Deferred revenue 41,500   41,500   41,500    
Current liability $ 10,400   $ 10,400   10,400    
License and Collaboration Agreement with Regeneron | Private Placement [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Regulatory milestone payments         $ 575,000